EXIRIS S.R.L.
1Patents
1Active
1Granted
38Portfolio score
Filing activity: Aug 1, 2018 → Aug 1, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11643467B2 | Monoclonal antibody anti-FGFR4 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.